Predict your next investment

Eyetronic Therapie company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
eyetronic-therapie.de

See what CB Insights has to offer

Total Raised

$12.99M

Investors Count

4

Deal Terms

2

Eyetronic Therapie Funding, Eyetronic Therapie Valuation & Eyetronic Therapie Revenue

5 Fundings

Eyetronic Therapie's latest funding round was a Unattributed VC for $3.53M on August 9, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/9/2017

Unattributed VC

$3.53M

$0.00B

((9.99x))

FY 1234

1

8/19/2015

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

6/11/2013

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

1/14/2010

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

3/4/2009

Seed VC

$99M

$0.00B

((9.99x))

FY 1234

10

Date

8/9/2017

8/19/2015

6/11/2013

1/14/2010

3/4/2009

Round

Unattributed VC

Series C

Series B

Series A

Seed VC

Amount

$3.53M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Eyetronic Therapie Deal Terms

2 Deal Terms

Eyetronic Therapie's deal structure is available for 2 funding rounds, including their Series B from June 11, 2013.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Eyetronic Therapie Investors

4 Investors

Eyetronic Therapie has 4 investors. Norgine Ventures invested in Eyetronic Therapie's Unattributed VC funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/9/2017

8/9/2017

1
Unattributed VC

Corporate Venture

United Kingdom

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Germany

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Germany

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Holding Company

Germany

First funding

8/9/2017

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/9/2017

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

1
Unattributed VC

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Corporate Venture

Venture Capital

Venture Capital

Holding Company

Location

United Kingdom

Germany

Germany

Germany

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.